Novel Personalized Management Approaches in Rheumatoid Arthritis

Program Overview

This case-based activity demonstrates the most effective approaches to instituting, monitoring, and revising therapy in the clinical setting and discusses new and emerging agents on the horizon. Test yourself against your peers and find out how the experts manage their patients.

Credit Expired

Target Audience

Rheumatologists – Relevant Terms: Rheumatoid Arthritis

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Utilize appropriate risk-assessment and monitoring tools for patients with rheumatoid arthritis (RA) to assess disease activity and direct individualized management decisions
  • Integrate new and emerging IL-6 directed therapies in RA for individualized treatment plans based on safety and efficacy data, patient selection data, and the rationale for targeting the IL-6 pathway
  • Incorporate strategies for a collaborative approach to RA care that includes a multidisciplinary team of health professionals and patient preferences into treatment selection

Activity Faculty

Vibeke Strand, MD, MACR, FACP

Vibeke Strand, MD, MACR, FACP

Adjunct Clinical Professor
Division of Immunology/Rheumatology
Stanford University School of Medicine
Stanford, CA

Martin Jan Bergman, MD, FACR, FACP, FCPP

Martin Jan Bergman, MD, FACR, FACP, FCPP

Clinical Associate Professor, Medicine
Drexel University School of Medicine
Philadelphia, PA

Eric M. Ruderman, MD

Eric M. Ruderman, MD

Professor, Medicine
Department of Rheumatology
Northwestern University
Chicago, IL


Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources